These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings. Parlier V, van Melle G, Beris P, Schmidt PM, Tobler A, Haller E, Bellomo MJ. Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157 [Abstract] [Full Text] [Related]
6. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis]. Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M. Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664 [Abstract] [Full Text] [Related]
7. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance. Werner M, Maschek H, Kaloutsi V, Choritz H, Georgii A. Virchows Arch A Pathol Anat Histopathol; 1992 Jan; 421(1):47-52. PubMed ID: 1636249 [Abstract] [Full Text] [Related]
8. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival. Bernasconi P, Alessandrino EP, Boni M, Bonfichi M, Morra E, Lazzarino M, Campagnoli C, Astori C. Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176 [Abstract] [Full Text] [Related]
9. Cytogenetic analysis and RAS mutations in primary myelodysplastic syndromes. Plata E, Viniou N, Abazis D, Konstantopoulos K, Troungos C, Vaiopoulos G, Meletis J, Kittas C, Pangalos C, Yataganas X. Cancer Genet Cytogenet; 1999 Jun; 111(2):124-9. PubMed ID: 10347548 [Abstract] [Full Text] [Related]